The global transcatheter mitral valve market is currently experiencing an unprecedented surge, poised for remarkable growth and innovation in the coming years. Recent comprehensive market research indicates that the industry is on track to reach a valuation of USD 933.9 Million by the close of 2022, with a projected compound annual growth rate (CAGR) of 13.5%. This upward trajectory is expected to elevate the market to an impressive USD 3.3 Billion by 2032.
This phenomenal growth is underpinned by groundbreaking advancements in medical technology, coupled with the escalating prevalence of cardiovascular diseases on a global scale. Transcatheter mitral valve procedures are witnessing a significant uptick in demand, fueled by their minimally invasive nature, offering patients a viable alternative to traditional open-heart surgeries.
Request A Report Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-15165
Edwards Lifesciences is a prominent medical device company that specializes in cardiovascular technologies. One of its notable products is the Edwards Lifesciences Transcatheter Mitral Valve (TMV) system, developed in collaboration with Abbott, a global healthcare company.
Key factors driving the expansion of the transcatheter mitral valve market include:
- Breakthrough innovations in medical devices and procedural techniques are revolutionizing the treatment landscape for mitral valve disorders, enabling safer and more efficacious interventions.
- The escalating burden of cardiovascular conditions worldwide, including mitral valve diseases, is driving the demand for minimally invasive treatment options, fostering market growth.
- Transcatheter mitral valve procedures offer patients shorter recovery times, reduced hospital stays, and lower risk of complications compared to traditional surgical interventions, aligning with the growing trend towards patient-centered care.
The exponential growth trajectory of the transcatheter mitral valve market underscores the pivotal role of innovation in reshaping the future of cardiac care. With continued advancements in technology and a growing emphasis on patient-centric solutions, the stage is set for unprecedented growth and transformative outcomes in the years ahead.
Ask for Customize Research Report: https://www.futuremarketinsights.com/customization-available/rep-gb-15165
Competitive Landscape: Transcatheter Mitral Valve Market
The transcatheter mitral valve market is consolidated with the presence of various established players across the globe. Key players are enforcing clinical evaluations of pipelined products to strengthen their market positions. They are also investing huge sums in research and development activities to generate more revenues in the global market.
- In March 2022, Edwards Lifesciences received approval from the U.S. Food and Drug Administration (FDA) for its MITRIS RESILIA valve. It is a tissue valve replacement which is specifically designed for the heart’s mitral position.
- In April 2020, Abbott received the CE Mark approval for its Tendyne Transcatheter Mitral Valve Implantation System and TriClip Transcatheter Tricuspid Valve Repair System under its structural heart device portfolio.
Transcatheter Mitral Valve Market Outlook by Category:
By Product:
- Transcatheter Mitral Valve Replacement
- Transcatheter Mitral Valve Repair
By Indication:
- Mitral Stenosis
- Mitral Regurgitation
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratories
A Full Report Overview: https://www.futuremarketinsights.com/checkout/15165
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube